Maria J. Gama
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 21, 2023
New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 07, 2023
NPC1-like phenotype, with intracellular cholesterol accumulation and altered mTORC1 signaling in models of Parkinson's disease.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 09, 2023
Altered expression of Sialyl Lewis X in experimental models of Parkinson's disease.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: May 16, 2023
Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance.
Journal: Molecules (Basel, Switzerland)
Published: February 28, 2022
Perceptions of Sexual Abuse in Sport: A Qualitative Study in the Portuguese Sports Community.
Journal: Frontiers in sports and active living
Published: December 17, 2021
Corrigendum to "Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy" [Mol. Cell. Neurosci., Volume 96, April 2019, Pages 1-9.].
Journal: Molecular and cellular neurosciences
Published: May 17, 2021
Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease.
Journal: Cell death & disease
Published: August 22, 2019
Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy.
Journal: Molecular and cellular neurosciences
Published: December 03, 2018
Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.
Journal: Molecular neurobiology
Published: January 24, 2018
Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson's disease.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 21, 2017
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.
Journal: Experimental neurology
Published: January 30, 2017
Last Updated: 09/26/2026